Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Levomefolate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II/ Phase III
Sponsor : Pamlab
Deal Size : Inapplicable
Deal Type : Inapplicable
L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults
Details : L-Methylfolate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Attention Deficit Disorder with Hyperactivity.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 14, 2013
Lead Product(s) : Levomefolate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II/ Phase III
Sponsor : Pamlab
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Levomefolate
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Goldfarb Foundation | Pamlab
Deal Size : Inapplicable
Deal Type : Inapplicable
Metanx Effects on Nerve Fiber Density in Neuropathic Diabetics
Details : L-Methylfolate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 04, 2012
Lead Product(s) : Levomefolate
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Goldfarb Foundation | Pamlab
Deal Size : Inapplicable
Deal Type : Inapplicable